The Radionuclide Drug Conjugates (RDC) Market focuses on therapeutic and diagnostic approaches that combine targeting molecules with radioactive isotopes. These agents are being investigated and developed to deliver radiation to specific biological targets, particularly in oncology, while supporting more targeted approaches to disease management.
Current Market Landscape
Interest in RDCs is...
The Radionuclide Drug Conjugates (RDC) Market relates to therapeutic approaches that combine radioactive isotopes with targeting molecules designed to deliver radiation to selected biological targets. These technologies are being investigated particularly in oncology, where targeted radiation may help treat specific tumors.
Current Market Landscape
The field includes radiopharmaceutical...
English
Arabic
French
Spanish
Portuguese
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek